Systemic Literature Review to Characterize the Burden and Unmet Needs Associated with Cremophor EL

Home / Intelligence / Scientific Publications / Systemic Literature Review to Characterize the Burden and Unmet Needs Associated with Cremophor EL

Cremophor EL (CrEL) is an additive (excipient) used to improve the solubility of hydrophobic drugs including certain anti-cancer drugs, like paclitaxel. Although the potential toxicities associated with CrEL are well known, the burden of CrEL-containing therapy is not well defined in the published scientific literature.


Authors

Brixner D, McKinley K, Gelder M, Oak B, Dehipawala S, Hadker N

Journal

ISPOR Meeting 2021

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.